States Confront Oversight of Medical Chatbots While FDA Stands Down: Implications From Pennsylvania’s Character.AI Lawsuit
May 14, 2026Technology, Artificial Intelligence, Regulatory, Food and Drug Administration (FDA), State Regulations
As medical chatbots proliferate, a new Pennsylvania lawsuit highlights a developing trend of states leading health artificial intelligence (AI) enforcement efforts, while the Food and Drug Administration (FDA) appears to be on the sidelines.
Get the latest FDA and related regulatory developments critical to the life sciences industry delivered to your inbox.
